DBD vs MCK · P/E 28, rev $3.75B vs P/E 20, rev $403.43B
Diebold Nixdorf, Incorporated (DBD) versus McKesson Corporation (MCK) — a side-by-side from cached financials, not a winner call.
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
DBD currently screens at market cap $2.82B and trailing P/E 28.1. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Not investment advice. Open the DBD and MCK stock pages for the full models.
Not investment advice.